Crossmark

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort

Crossref DOI link: https://doi.org/10.1186/s12885-018-4111-5

Published Online: 2018-02-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bosco, Cecilia

Garmo, Hans

Hammar, Niklas

Walldius, Göran

Jungner, Ingmar

Malmström, Håkan

Holmberg, Lars

Van Hemelrijck, Mieke
Funding

Funding for this research was provided by:

Cancerfonden
More Information

Article History

Received: 10 August 2017

Accepted: 8 February 2018

First Online: 20 February 2018

Ethics approval and consent to participate

: This study complied with the Declaration of Helsinki, and the ethics review board of the Karolinska Institute approved the study (diary number: 2010/1047–31/1). As with all national register data studies in Sweden, the need for consent has been waived by the ethics review board of the Karolinska Institute.

: NA.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below